Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

LGND
Healthcare|Biotechnology|USA
$316.24
-6.50 (-2.01%)
DCF (FCF)
$71.09
Tangible Book
$33.87
Graham Number
$79.73
Earnings Power
$30.25

About

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Stock Price

+153.0%(1Y)

Pipeline Summary

41 total trials
12
Phase 1
24
Phase 2
4
Phase 3
1
Phase 4
Withdrawn: 2Completed: 37Terminated: 2

BioScore

2.8/10
High Risk

Ownership

Recent Insider Trades

Reardon AndrewSELL
2026-07-015,000 shares @ $313.28
Sabba Stephen LSELL
2026-06-162,145 shares @ $254
Haas JasonSELL
2026-06-126,461 shares @ $255.58
Aryeh JasonSELL
2026-06-115,000 shares @ $250
LAMATTINA JOHN LSELL
2026-06-104,591 shares @ $250.88

Recent News

2026-07-09 12:01:25
2026-07-08 16:03:16
2026-06-23 12:50:48
2026-06-23 09:57:55
2026-06-22 12:01:26
Data last updated: Jul 12, 2026, 07:42 PM